BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,217,000 | -81.1% | 189,900 | -76.5% | 0.07% | -83.6% |
| Q3 2020 | $43,581,000 | -23.9% | 807,800 | -13.8% | 0.41% | -25.3% |
| Q2 2020 | $57,231,000 | +58.4% | 937,595 | +19.2% | 0.55% | +26.7% |
| Q1 2020 | $36,137,000 | -25.3% | 786,265 | +42.7% | 0.43% | 0.0% |
| Q4 2019 | $48,348,000 | – | 550,975 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |